PBSV
Pharma-Bio Serv, Inc.
Key Financials
Operating Income
$-637662
↑ 50.5%
Revenue
$9.0M
↓ 5.3%
Net Income
$-100463
↑ 87.1%
Total Assets
$13.7M
↓ 16.2%
Gross Profit
$2.9M
↑ 15.7%
Shareholders' Equity
$11.9M
↓ 13.1%
EPS (Diluted)
$-0.00
↑ 88.2%
Total Liabilities
$1.7M
↓ 32.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 6/15/2026 | View on SEC |
| 10-Q | 6/15/2026 | View on SEC |
| 8-K | 5/15/2026 | View on SEC |
| ARS | 4/16/2026 | View on SEC |
| DEF 14A | 4/16/2026 | View on SEC |
| 8-K | 3/17/2026 | View on SEC |
| 10-Q | 3/17/2026 | View on SEC |
| 10-K/A | 2/27/2026 | View on SEC |
| 8-K | 1/29/2026 | View on SEC |
| 10-K | 1/29/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PBSV |
| Company Name | Pharma-Bio Serv, Inc. |
| CIK | 1304161 |
| Sector | Services-Management Consulting Services |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 8742 |
| SIC Description | Services-Management Consulting Services |
| Entity Type | operating |
| Fiscal Year End | 1031 |
| Phone | 787-278-2709 |